Inventaire - your friends and communities are your best library

Gene expression profiling of ampullary carcinomas classifies ampullary carcinomas into biliary-like and intestinal-like subtypes that are prognostic of outcome

author

Robert Grützmann

Katherine Stemke-Hale

Christian Pilarsky

Scott Kopetz

Huamin Wang

published in: PLOS One

date of publication: 2013-06-11

language: English

Cites articles 32

Date

Title

Authors

2013-05-22

A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy

Sarah J. Fleming
2012-07-01

Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial

Trevor F Cox, Juan Valle, John P Neoptolemos, Markus M Lerch, Bengt Glimelius, Markus Büchler, Amit M Oza, Christos Dervenis
2011-05-24

Clusterin confers gemcitabine resistance in pancreatic cancer
2011-03-24

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
2011-08-01

Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection

Christian Pilarsky, Hans-Detlev Saeger, Florian Ehehalt
2011-02-01

Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications

Stefan Schulz, Christoph Röcken, Peter Neuhaus, Wilko Weichert
2010-04-01

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

David Cunningham
2010-02-02

Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set

Hyun Goo Woo, Jae-Ho Cheong, Levi A Garraway, Gordon B. Mills, Bryan T. Hennessy
2009-01-01

Clusterin and chemoresistance
2009-02-01

Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer

Scott A. Waldman
2009-01-21

Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater

Scott Kopetz
2009-05-01

Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.

Luigi Tornillo, Arndt Hartmann
2009-01-23

Assessment of survival advantage in ampullary carcinoma in relation to tumour biology and morphology

Chandra Bhati
2008-08-01

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

Katherine Stemke-Hale, René Bernards, Marc van de Vijver, Ana Maria Gonzalez-Angulo, Gordon B. Mills, Joe W Gray, Bryan T. Hennessy, Mien-Chie Hung
2008-06-11

Pancreatobiliary versus intestinal histologic type of differentiation is an independent prognostic factor in resected periampullary adenocarcinoma

Ivar Prydz Gladhaug
2008-08-09

Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients

Daniele Santini, Sergio Morini, Roberto Coppola, Giuseppe Tonini, Giuseppe Perrone, Armando Antinori, Rossana Alloni, Pierfilippo Crucitti
2008-03-14

An audit of outcomes of a series of periampullary carcinomas

Antanas Gulbinas, Jorg Kleeff, Helmut Friess, Markus Büchler, Wolfgang Wagner
2008-01-10

Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer.

Daniele Santini, Bruno Vincenzi, Sergio Morini, Roberto Coppola, Giuseppe Tonini, John R. Mackey
2007-03-05

Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study

William Reinhold
2007-09-01

The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis
2007-07-26

Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability

Daniela Furlan
2005-03-01

Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater

Andrew Biankin, Steven T. Piantadosi, Michael Goggins, Anirban Maitra, Charles J Yeo, Steven Leach, Pedram Argani, Donna E Hansel
2004-01-01

Pathogenesis of carcinoma of the papilla of Vater
2004-07-06

Integrated genomic and proteomic analyses of gene expression in Mammalian cells

Ruedi Aebersold, Jimmy K. Eng, David R Goodlett, Leroy Hood, Serguei B Stepaniants, Megan C Feetham, Michelle R Doyle, Hongyue Dai, Vesteinn Thorsson, Bert Gunter, Peter S Linseley, Roland B Stoughton, William Hanlon
2004-05-01

MUC1 and MUC2 in pancreatic neoplasia

Olca Basturk, Edi Levi, Volkan Adsay, David S Klimstra
2004-07-01

Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up
2003-02-15

Summaries of Affymetrix GeneChip probe level data

Terry Speed, Rafael Irizarry
1999-08-01

Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater
1998-01-01

The Cdx-1 and Cdx-2 homeobox genes in the intestine
1997-08-01

Cloning and expression of the mRNA of human galectin-4, an S-type lectin down-regulated in colorectal cancer
1997-07-01

Characterization of posttranslational modifications of human A33 antigen, a novel palmitoylated surface glycoprotein of human gastrointestinal epithelium

Joan K. Heath, Richard Simpson, Lloyd J. Old
1994-02-01

Different clinicopathologic findings in two histologic types of carcinoma of papilla of Vater

Article - wd:Q36919864

Welcome to Inventaire

the library of your friends and communities

learn more